BlackRock Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$854M Buy
7,381,858
+570,689
+8% +$63.6M 0.41% 50
2016
Q3
$712M Buy
6,811,169
+172,828
+3% +$18.7M 0.36% 54
2016
Q2
$655M Sell
6,638,341
-901,757
-12% -$93.3M 0.34% 56
2016
Q1
$755M Buy
7,540,098
+3,023
+0% +$311K 0.41% 49
2015
Q4
$903M Buy
7,537,075
+81,481
+1% +$9.43M 0.5% 42
2015
Q3
$806M Buy
7,455,594
+217,996
+3% +$27.1M 0.48% 47
2015
Q2
$838M Sell
7,237,598
-51,988
-0.7% -$5.94M 0.46% 47
2015
Q1
$840M Sell
7,289,586
-171,290
-2% -$20.5M 0.45% 48
2014
Q4
$835M Buy
7,460,876
+371,332
+5% +$39.2M 0.45% 46
2014
Q3
$672M Sell
7,089,544
-58,082
-0.8% -$5.24M 0.39% 52
2014
Q2
$614M Buy
7,147,626
+160,982
+2% +$12.2M 0.36% 62
2014
Q1
$488M Buy
6,986,644
+58,060
+0.8% +$4.6M 0.31% 67
2013
Q4
$585M Sell
6,928,584
-694,952
-9% -$55M 0.38% 55
2013
Q3
$588M Buy
7,623,536
+620,448
+9% +$43.5M 0.4% 52
2013
Q2
$410M Buy
+7,003,088
New +$421M 0.31% 63

Other funds holding CELG